Concomitant Use of Antiplatelet Therapy With Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

Study Questions:

What is the effect of concomitant antiplatelet therapy on the safety and efficacy of dabigatran versus warfarin for the prevention of stroke or systemic embolism (SSE) in atrial fibrillation?